Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

An explorative metabolomic analysis of the endothelium in pulmonary hypertension

Research output: Contribution to journalJournal articlepeer-review

  1. Exercise suppresses tumor growth independent of high fat food intake and associated immune dysfunction

    Research output: Contribution to journalJournal articlepeer-review

  2. Initial evidence of abnormal brain plasticity in anorexia nervosa: an ultra-high field study

    Research output: Contribution to journalJournal articlepeer-review

  3. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation

    Research output: Contribution to journalJournal articlepeer-review

  4. Time to CT scan for patients with acute severe neurological symptoms: a quality assurance study

    Research output: Contribution to journalJournal articlepeer-review

View graph of relations

Pulmonary hypertension (PH) is classified into five clinical diagnostic groups, including group 1 [idiopathic pulmonary arterial hypertension (IPAH) and connective tissue disease-associated PAH (CTD-aPAH)] and group 4 (chronic thromboembolic pulmonary hypertension (CTEPH)). PH is a progressive, life-threatening, incurable disease. The pathological mechanisms underlying PH remain elusive; recent evidence has revealed that abnormal metabolic activities in the endothelium may play a crucial role. This research introduces a novel approach for studying PH endothelial function, building on the genome-scale metabolic reconstruction of the endothelial cell (EC) to investigate intracellular metabolism. We demonstrate that the intracellular metabolic activities of ECs in PH patients cluster into four phenotypes independent of the PH diagnosis. Notably, the disease severity differs significantly between the metabolic phenotypes, suggesting their clinical relevance. The significant metabolic differences between the PH phenotypes indicate that they may require different therapeutic interventions. In addition, diagnostic capabilities enabling their identification is warranted to investigate whether this opens a novel avenue of precision medicine.

Original languageEnglish
Article number13284
JournalScientific Reports
Volume12
Issue number1
Pages (from-to)13284
ISSN2045-2322
DOIs
Publication statusPublished - 2 Aug 2022

Bibliographical note

© 2022. The Author(s).

    Research areas

  • Connective Tissue Diseases, Endothelium/metabolism, Familial Primary Pulmonary Hypertension/metabolism, Humans, Hypertension, Pulmonary, Lung/metabolism

ID: 80062731